Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
Top Cited Papers
- 10 September 2020
- journal article
- letter
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 383 (11), 1085-1087
- https://doi.org/10.1056/NEJMc2025179
Abstract
Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined with a mean half-life of approximately 36 days after recovery. Whether these results predict the duration of viral immunity in persons recovering from more severe cases of Covid-19 or those exposed to vaccines is unknown.Funding Information
- McCarthy Family Foundation
- AIDS Healthcare Foundation (Grant to OOY)
- National Institutes of National Institute of Allergy and Infectious Diseases (AI124979, AI131879, AI140775, UM1AI068616, UM1AI068632, UM1AI106716)
- Doris Duke Charitable Foundation (2019086)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Mental Health
- James B. Pendleton Charitable Trust
This publication has 6 references indexed in Scilit:
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Early maternal separation accelerates the progression of endometriosis in adult miceReproductive Biology and Endocrinology, 2020
- SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test SetupCurrent Protocols in Microbiology, 2020
- Living on Three Time Scales: The Dynamics of Plasma Cell and Antibody Populations Illustrated for Hepatitis A VirusPLoS Computational Biology, 2012
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryThe New England Journal of Medicine, 2007
- Longitudinal Analysis of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibody in SARS PatientsClinical and Vaccine Immunology, 2005